Topical NSAID – Combines 2% diclofenac sodium with the transdermal drug carrier dimethyl sulfoxide (DMSO)
- Indication: Treating the pain of osteoarthritis of the knee.
- Low systemic exposure to minimize side effects.
- Metered dose dispenser.
- Intellectual Property
- Patents issued in nineteen countries (ex-U.S.) and pending in five countries with the latest expiring 2027.
Awaiting DCGI approval